The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition

Cell Death and Differentiation

Volumn 19, Issue 3, 2012, Pages 488-500

  Vilotti, S ^a,b   Biagioli, M ^a   Foti, R ^c,d   Dal Ferro, M ^a,b   Lavina, Z Scotto ^c,d   Collavin, L ^c,d   Del Sal, G ^c,d   Zucchelli, S ^a,b,e   Gustincich, S ^a,b,e  

^a SISSA   (Italy)

^b Giovanni Armenise Harvard Foundation Laboratory   (Italy)

^c Lab Naz Consorzio I   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

nucleolus; PML; proteasome inhibition; rRNA biogenesis; TTRAP

Indexed keywords

5' TYROSYL DNA PHOSPHODIESTERASE; BETA ACTIN; PHOSPHODIESTERASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEIN TTRAP; RECEPTOR PROTEIN; RETINOBLASTOMA PROTEIN; RIBOSOME RNA; RNA PRECURSOR; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEOLUS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RIBOSOME; RNA PROCESSING; SIGNAL TRANSDUCTION; STRESS;

CELL LINE, TUMOR; CELL NUCLEOLUS; HEK293 CELLS; HUMANS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RIBOSOMES; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84857061422     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.118     Document Type: Article

References (40)

1. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW. A human 50-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 2009; 461: 674-678.
2. Rodrigues-Lima F, Josephs M, Katan M, Cassinat B. Sequence analysis identifies TTRAP, a protein that associates with CD40 and TNF receptor-Associated factors, as a member of a superfamily of divalent cation-dependent phosphodiesterases. Biochem Biophys Res Commun 2001; 285: 1274-1279. (Pubitemid 32912921)
3. Pype S, Declercq W, Ibrahimi A, Michiels C, Van Rietschoten JG, Dewulf N et al. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-Associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem 2000; 275: 18586-18593. (Pubitemid 30414822)
4. Pei H, Yordy JS, Leng Q, Zhao Q, Watson DK, Li R. EAPII interacts with ETS1 and modulates its transcriptional function. Oncogene 2003; 22: 2699-2709. (Pubitemid 36612035)
5. Esguerra CV, Nelles L, Vermeire L, Ibrahimi A, Crawford AD, Derua R et al. Trap is an essential modulator of Smad3-dependent Nodal signaling during zebrafish gastrulation and left-right axis determination. Development 2007; 134: 4381-4393.
6. Hecker C, Rabiller M, Haglund K, Bayer P, Dikic I. Specification of SUMO1-And SUMO2-interacting motifs. J Biol Chem 2006; 281: 16117-16127.
7. Xu G, Pan Y, Wang B, Huang L, Tian L, Xue J et al. TTRAP is a novel PML nuclear bodiesassociated protein. Biochem Biophys Res Commun 2008; 375: 395-398.
8. Zucchelli S, Vilotti S, Calligaris R, Lavina ZS, Biagioli M, Foti R et al. Aggresome-forming TTRAP mediates pro-Apoptotic properties of Parkinson's disease-Associated DJ-1 missense mutations. Cell Death Differ 2009; 16: 428-438.
9. Li C, Fan S, Owonikoko TK, Khuri FR, Sun S, Li R. Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway. Oncogne 2011; 30: 3802-3812.
10. Lee HY, Youn SW, Kim JY, Park KW, Hwang CI, Park WY et al. FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappaB. Arterioscler Thromb Vasc Biol 2008; 1: 112-120.
11. Mattsson K, Pokrovskaja K, Kiss C, Klein G, Szekely L. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci USA 2001; 98: 1012-1017. (Pubitemid 32121178)
12. Karni-Schmidt O, Zupnick A, Castillo M, Ahmed A, Matos T, Bouvet P et al. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. J Cell Sci 2008; 121: 4098-4105.
13. Krüger T, Scheer U. p53 localizes to intranucleolar regions distinct from the ribosome production compartments. J Cell Sci 2010; 123: 1203-1208.
14. Shen TH, Lin H, Scaglioni PP, Yung TM, Pandolfi PP. The mechanisms of PML-nuclear body formation. Mol Cell 2006; 24: 331-339. (Pubitemid 44647906)
15. Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z et al. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 2005; 24: 5401-5413. (Pubitemid 43080084)
16. Perry RP, Kelley DE. Inhibition of RNA synthesis by actinomycin D: Characteristic doseresponse of different RNA species. J Cell Physiol 1970; 76: 127-139.
17. Murayama A, Ohmori K, Fujimura A, Minami H, Yasuzawa-Tanaka K, Kuroda T et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 2008; 133: 627-639. (Pubitemid 351636301)
18. Henras AK, Soudet J, Gérus M, Lebaron S, Caizergues-Ferrer M, Mougin A et al. The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell Mol Life Sci 2008; 65: 2334-2359.
19. Dez C, Houseley J, Tollervey D. Surveillance of nuclear-restricted pre-ribosomes within a subnucleolar region of Saccharomyces cerevisiae. EMBO J 2006; 25: 1534-1546.
20. LaRiviere FJ, Cole SE, Ferullo DJ, Moore MJ. A late-Acting quality control process for mature eukaryotic rRNAs. Mol Cell 2006; 24: 619-626. (Pubitemid 350284228)
21. Blaise R, Masdehors P, Laugé A, Stoppa-Lyonnet D, Alapetite C, Merle-Béral H et al. Chromosomal DNA and p53 stability, ubiquitin system and apoptosis in B-CLL lymphocytes. Leuk Lymphoma 2001; 42: 1173-1180. (Pubitemid 34082905)
22. Stavreva DA, Kawasaki M, Dundr M, Koberna K, Müller WG, Tsujimura-Takahashi T et al. Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol Cell Biol 2006; 26: 5131-5145. (Pubitemid 43955825)
23. Campagnoli MF, Ramenghi U, Armiraglio M, Quarello P, Garelli E, Carando A et al. RPS19 mutations in patients with Diamond-Blackfan anemia. Hum Mutat 2008; 29: 911-920. (Pubitemid 351951285)
24. Narla A, Ebert BL. Ribosomopathies: Human disorders of ribosome dysfunction. Blood 2010; 115: 3196-3205.
25. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003; 3: 179-192. (Pubitemid 37328870)
26. Burger K, Mühl B, Harasim T, Rohrmoser M, Malamoussi A, Orban M et al. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J Biol Chem 2010; 285: 12416-12425.
27. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 2005; 7: 311-318. (Pubitemid 40331133)
28. Robledo S, Idol RA, Crimmins DL, Ladenson JH, Mason PJ, Bessler M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 2008; 14: 1918-1929.
29. Finkbeiner E, Haindl M, Muller S. The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex. EMBO J 2011; 30: 1067-1078.
30. Pontes O, Li CF, Nunes PC, Haag J, Ream T, Vitins A et al. The Arabidopsis chromatinmodifying nuclear siRNA pathway involves a nucleolar RNA processing center. Cell 2006; 126: 79-92. (Pubitemid 44026550)
31. Lebreton A, Tomecki R, Dziembowski A, Séraphin B. Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature 2008; 456: 993-996.
32. Allmang C, Kufel J, Chanfreau G, Mitchell P, Petfalski E, Tollervey D. Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J 1999; 18: 5399-5410. (Pubitemid 29465589)
33. Zhou Y, Schmitz K, Mayer C, Yuan X, Akhtar A, Grummt I. Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing. Nat Cell Biol 2009; 11: 1010-1016.
34. Tanaka Y, Okamoto K, Teye K, Umata T, Yamagiwa N, Suto Y et al. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation. EMBO J 2010; 29: 1510-1522.
35. Andersen JS, Lam YW, Leung AKL, Ong S, Lyon CE, Lamond AI et al. Nucleolar proteome dynamics. Nature 2005; 433: 77-83. (Pubitemid 40101146)
36. McMahon M, Ayllón V, Panov KI, O'Connor R. Ribosomal 18 S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation. J Biol Chem 2010; 285: 18309-18318.
37. Wang Y, Zhu W, Levy DE. Nuclear and cytoplasmic mRNA quantification by SYBR green based real-time RT-PCR. Methods 2006; 39: 356-362. (Pubitemid 44354204)
38. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 2000; 19: 6185-6195.
39. Zucchelli S, Codrich M, Marcuzzi F, Pinto M, Vilotti S, Biagioli M et al. TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains. Hum Mol Genet 2010; 19: 3759-3770.
40. Morello LG, Hesling C, Coltri PP, Castilho BA, Rimokh R, Zanchin NIT. The NIP7 protein is required for accurate pre-rRNA processing in human cells. Nucleic Acids Res 2010; 39: 648-665.